Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer - Wikidata - wikimedia - TriplyDB

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer

http://www.wikidata.org/entity/Q28258903

about

Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines A role for tumor protein TPD52 phosphorylation in endo-membrane trafficking during cytokinesis Gene expression differences predict treatment outcome of merkel cell carcinoma patients Overexpressed oncogenic tumor-self antigens The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.Role of annexin A6 in cancer.Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage.DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52.BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications.The testicular germ cell tumour transcriptome.All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.Genomic copy number and expression patterns in testicular germ cell tumours.Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of Chondrocytes Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.Androgen-dependent alternative mRNA isoform expression in prostate cancer cells

P2860

Q27333989-20A53983-0D30-4B71-BC47-B99784C8F225 Q30587051-34E09C18-F8E4-487A-B827-7F89D4F57CEE Q33239655-3201F624-A58A-4D41-BE97-A8C2A3556BA2 Q33406769-65E05559-AB9D-48CC-B991-FF66F761D17D Q33694015-7B779242-32B0-494F-90CB-D951DA242DE1 Q33745941-D447D417-C503-4D5D-B4A2-5E09CEF1E109 Q34239148-B9F58065-C07D-4C0D-BF72-75C051F424C3 Q34517584-11936DCE-7153-41B0-ABDE-32C5E07EF169 Q35122235-0215E2C5-5ACB-41BF-B8BB-D663114AF2A8 Q35886756-F899300D-2DEC-4AEA-A9D9-58FA5713E3DC Q35891644-BA3E88CD-BC80-4F2F-87FC-8AD4075A495E Q36085446-C9E75E50-805B-4576-8D2B-6CA9C31A88D3 Q36905913-84096C2B-4EF0-4974-86C5-3212E43C1D45 Q37195269-5AB21AE0-3171-4395-A3F2-BADB772B0D8E Q37219890-7212752C-E9D7-4829-BDFB-7E09918A5501 Q37308114-7A044340-54BE-47E6-A0C7-1D391603AECE Q37344530-C59D37D4-4ADD-42FC-9142-9D700490826D Q37770590-ECB37C57-7A23-4E83-8D2B-C102CFF2B9D7 Q37886262-FF61DBFF-9C7B-451C-9404-DD56FF89F6B4 Q38823738-DDA39150-3091-4658-9C1D-184CA24A7F6E Q38880242-25CE354A-BD6A-48A5-9BB5-469F287AA30D Q39384713-37FBB56A-373E-4972-875A-22C56A1B38CA Q39923830-740FF443-5E4A-4ED6-9137-100C3DB53B1B Q40039629-559F682F-9634-4A0F-8F1E-5FEB93617AEB Q41180083-FD8634D8-64B5-46D7-B361-73E3B2DC8855 Q51022990-0BC943D1-C4E1-4310-9395-EA6B183749B1 Q54441612-A168648C-4E9E-42BB-8A3D-C93E72A8F376 Q57135534-169897BC-E3E6-47DB-8D13-99A241562D84

P2860

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer

http://www.wikidata.org/entity/Q28258903

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@ast

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@en

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@nl

type

label

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@ast

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@en

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@nl

prefLabel

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@ast

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@en

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@nl

P1433

Q28258903-8F14BD74-DA1F-4A19-B1C3-0FBE59767B28

P1476

Q28258903-C9073C41-C175-44A2-BF1E-A2E1C9E6BA5F

P2093

Q28258903-1B660454-24B0-408C-9037-039245D522BB

Q28258903-42A65B9C-7EF9-45E1-9FE7-FDC1B45EC693

Q28258903-75BBB86C-37C5-4C58-B6D6-B46E9150026A

Q28258903-8DA34539-B41A-4E99-98B9-4F971E8CB4F9

Q28258903-B943336D-1A17-4E1E-AF71-B514E18D754C

Q28258903-C0043F39-FAB7-476D-B5AF-BE465B824880

Q28258903-CA01982C-59FA-48E8-ADB3-650A986D15BB

Q28258903-D761CE15-0F65-447A-8111-9DE412418415

Q28258903-DAB210A9-E096-44AF-8F2C-3ECBCD829523

Q28258903-F0C096C8-2568-4C78-BFE5-B799F460600A

P2860

Q28258903-3E54D728-0774-41D2-9D81-AF0D003E731F

Q28258903-40A86354-C6D9-49EF-932E-6D15BECEED6E

Q28258903-425D802B-CBA9-4891-A906-68CF5861D9E4

P304

Q28258903-2AD88815-FFDC-40F7-ABDD-0BA7B5559E07

P31

Q28258903-BF79E031-812A-4257-A6EC-9B4CBA67B907

P3181

Q28258903-17F96CEE-03BD-4A5C-A4F9-DD0A2324F431

P356

Q28258903-BD0EC6AE-B923-4B38-B784-401DF6573349

P407

Q28258903-BCA9DC9F-6079-4F81-89A9-7730868AE562

P433

Q28258903-00DD44A4-E79F-4FFA-B00A-7C8CF3DDBBAD

P478

Q28258903-661FCE57-F54D-49C4-904B-C5A1F5C74374

P50

Q28258903-239B1D7C-5B39-4106-A685-182DAF0570EC

Q28258903-2FA6A7B4-6B84-433A-A57D-7D32DBAFB9D0

Q28258903-8C1CB8C0-E2AD-45FC-A7DD-8FF9AF74E453

P577

Q28258903-C50699ED-F3C3-4956-9B75-271BF997032A

P5875

Q28258903-F4B3F481-8478-4F4D-AED6-769580C502B7

P698

Q28258903-25145B44-BED7-4A0A-B287-189C24E1A153

P921

Q28258903-56984137-07FD-4C14-98E7-C4CC35198FB3

Q28258903-8EA4F367-7185-4503-B15F-D260F3CD66BE

P3181

P356

P1433

International Journal of Cancer

P1476

Tumor protein D52 (TPD52) is o ...... ation target in ovarian cancer

@en

P2093

Beth Y Karlan

http://www.w3.org/2001/XMLSchema#string

Dennis J Slamon

http://www.w3.org/2001/XMLSchema#string

Gregory B Peters

http://www.w3.org/2001/XMLSchema#string

Janelle Mercieca

http://www.w3.org/2001/XMLSchema#string

Karen Byth

http://www.w3.org/2001/XMLSchema#string

Luke St Heaps

http://www.w3.org/2001/XMLSchema#string

Marlena Schoenberg Fejzo

http://www.w3.org/2001/XMLSchema#string

Rosemary L Balleine

http://www.w3.org/2001/XMLSchema#string

Yael Livnat

http://www.w3.org/2001/XMLSchema#string

Yoke-Eng Chiew

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines

Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins.

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.

P304

1049-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3038088

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/IJC.21250

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer A. Byrne

P577

2005-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7758351

http://www.w3.org/2001/XMLSchema#string

P698

15986428

http://www.w3.org/2001/XMLSchema#string

P921